ciprofloxacin has been researched along with Porphyria Cutanea Tarda in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mazzarolo, SS | 1 |
Degiovanni, CV | 1 |
Darley, CR | 1 |
2 other studies available for ciprofloxacin and Porphyria Cutanea Tarda
Article | Year |
---|---|
Blistering eruption on the leg of an adult.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Blister; Ciprofloxacin; Dermatitis Herpetiformis; D | 2011 |
Pseudoporphyria occurring during a course of ciprofloxacin.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; False Positive Reactions; Hand; | 2008 |